A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for sunitinib

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for sunitinib

BackgroundSunitinib is approved for the treatment of metastatic renal cell carcinoma (mRCC), imatinib-resistant gastrointestinal stromal tumors (GIST), and advanced pancreatic neuroendocrine tumors (PNET). This study aims to investigate the safety profiles of sunitinib through data mining of the US...

Full description

Saved in:
Bibliographic Details
Main Authors: Xusheng Zhang (Author), Xiuli Ren (Author), Tianyu Zhu (Author), Wanjin Zheng (Author), Chengwu Shen (Author), Cuicui Lu (Author)
Format: Book
Published: Frontiers Media S.A., 2024-07-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items